Trader Note — 9846 total
HYLN just dropped a Q1 earnings beat and rallied 16% on the week — yet short sellers have barely flinched, leaving the stock in an unusual tug of war between improving fundamentals and a stubbornly elevated short…
IBEX Limited enters the post-earnings stretch with three signals pointing in the same direction — and a $20 million share repurchase program announced today that sharpens the setup further. The catalyst is last week's…
C4 Therapeutics heads into the week of May 11 with a striking divergence: short sellers are heavily dug in at more than a quarter of the free float, yet options traders are leaning bullish at a pace not seen in…
JZXN — Jiuzi Holdings — is a $1.6 million market-cap Chinese EV retail stock that just became one of the most expensive names to borrow in the market. The dominant story this week is a violent repricing in the lending…
DoubleDown Interactive closed its latest earnings week with a sharp analyst target cut and a stock price that has still run 34% in a month — the tension between those two facts defines the current setup. The most…
PMV Pharmaceuticals heads into its May 15 investor call with a conflicting set of signals: a Q1 earnings beat, a short-interest spike, and fresh analyst caution. The most notable piece of recent Street activity came…
COMPASS Pathways reported Q1 earnings on May 13 that beat estimates and flagged an accelerated FDA review timeline, delivering a jolt to a stock that had already climbed 69% over the prior month — and leaving a…
Praxis Precision Medicine heads into mid-May with a sharpening divergence between a cautious short base and a bullish analyst consensus that just got a fresh upward nudge. Short interest is meaningfully elevated but…
Shift4 Payments enters the week in an intriguing position: short interest is still among the heaviest in the payments universe, borrowing costs have collapsed, and the options market just registered its most defensive…
Legend Biotech enters the post-earnings week with shorts in rapid retreat and the Street scrambling to reprice a CARVYKTI royalty story that just posted its best quarterly revenue growth in two years. The catalyst is…
uCloudlink reported Q1 2026 results this morning — a revenue beat against estimates and in-line losses — yet the stock enters the week down 7% and has shed 14% over the past month. The tension is straightforward: new…
Kingsoft Cloud heads into its May 26 earnings call with the lending pool at maximum tightness — and short sellers paying a rising premium to hold positions. The most striking feature of KC's setup is not the size of…
C3.ai heads into its June 3 Q1 report with short sellers adding aggressively, options flipping bullish against the current, and a Street largely unconvinced the company can turn the corner. Short interest is the…
LTRN is navigating a uniquely charged 48 hours: a registered direct offering announced this morning collides with Q1 results due Thursday, all while short interest holds near a multi-month peak and the borrow market…
ZoomInfo Technologies entered this week's earnings report carrying a fragile price and a heavy short position. What followed was a rout — and the Street's reaction made the damage worse. The stock crashed 33% on…
MXCT reported Q1 2026 results on May 12 that cleared the revenue bar — yet the stock barely moved, closing at $0.82 and down about 2.4% on the week. That disconnect between an in-line print and a sub-$1 share price…
OCG — Oriental Culture Holding — heads into mid-May with its borrow market in a state of acute stress, sitting sharply at odds with a short interest percentage that remains modest on its own terms. The cost to borrow…
Sprout Social enters the week before its next scheduled event with an unusual combination of signals — short sellers have abandoned positions at pace, the stock has jumped 31% in a month, and yet company insiders have…
BYD delivered what looks like a textbook mixed quarter — and the market responded harshly. Q1 2026 was, by most headline metrics, a genuine record. Revenue hit CAD $997 million, up 28% year-over-year and the highest…
The Pennant Group has had an eventful week — a blowout Q1 print drove the stock up 13%, analysts lifted targets across the board, and short sellers retreated sharply. Then, on Wednesday, the Centers for Medicare &…
